Cargando…

Looking forward to new targeted treatments for chronic spontaneous urticaria

The introduction of omalizumab to the management of chronic spontaneous urticaria (CSU) has markedly improved the therapeutic possibilities for both, patients and physicians dealing with this disabling disease. But there is still a hard core of patients who do not tolerate or benefit from existing t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kocatürk, Emek, Maurer, Marcus, Metz, Martin, Grattan, Clive
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223554/ https://www.ncbi.nlm.nih.gov/pubmed/28078079 http://dx.doi.org/10.1186/s13601-016-0139-2

Ejemplares similares

Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)

Is chronic urticaria more than skin deep?
por: Kocatürk, Emek, et al.
Publicado: (2019)

In Chronic Spontaneous Urticaria, Comorbid Depression Linked to Higher Disease Activity, and Substance P Levels
por: Memet, Bachar, et al.
Publicado: (2021)

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
por: Krause, Karoline, et al.
Publicado: (2023)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
por: Metz, Martin, et al.
Publicado: (2020)

Coexistence of granuloma annulare and chronic spontaneous urticaria
por: Topal, Ilteris Oguz, et al.
Publicado: (2016)

Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria
por: Kocatürk, Emek, et al.
Publicado: (2019)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
por: Kocatürk, Emek, et al.
Publicado: (2023)

Urticaria in Pregnancy and Lactation
por: Kocatürk, Emek, et al.
Publicado: (2022)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

Follicular traction urticaria
por: Duman, Hatice, et al.
Publicado: (2016)

Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know
por: Terhorst-Molawi, Dorothea, et al.
Publicado: (2023)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?()
por: Kocatürk, Emek, et al.
Publicado: (2022)

Editorial: The complexity of urticaria
por: Makris, Michael, et al.
Publicado: (2023)

IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria?
por: Altrichter, Sabine, et al.
Publicado: (2011)

Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
por: Purayil, Saleema, et al.
Publicado: (2022)

On the Lipophilic Nature of Autoreactive IgE in Chronic Spontaneous Urticaria
por: Lakin, Elisa, et al.
Publicado: (2019)

The many faces of pediatric urticaria
por: Sekerel, Bulent Enis, et al.
Publicado: (2023)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
por: Weller, Karsten, et al.
Publicado: (2015)

Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients’ Quality of Life: a Prospective, Non-interventional Trial
por: Metz, Martin, et al.
Publicado: (2015)

A positive serum basophil histamine release assay is a marker for ciclosporin-responsiveness in patients with chronic spontaneous urticaria
por: Iqbal, Kamran, et al.
Publicado: (2012)

Treatment of Chronic Spontaneous Urticaria
por: Kaplan, Allen P.
Publicado: (2012)

STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
por: Sauer, Merle, et al.
Publicado: (2022)

Lower IgA Levels in Chronic Spontaneous Urticaria Are Associated With Lower IgE Levels and Autoimmunity
por: Sauer, Merle, et al.
Publicado: (2021)

Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
por: Kolkhir, Pavel, et al.
Publicado: (2021)

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria
por: Bernstein, Jonathan A., et al.
Publicado: (2023)

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria()
por: Metz, Martin, et al.
Publicado: (2022)

Expert consensus on practical aspects in the treatment of chronic urticaria
por: Bauer, Andrea, et al.
Publicado: (2021)

Management of chronic spontaneous urticaria: a worldwide perspective
por: Kolkhir, Pavel, et al.
Publicado: (2018)

Total IgE as a Marker for Chronic Spontaneous Urticaria
por: Altrichter, Sabine, et al.
Publicado: (2021)

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from the validation of the Polish Urticaria Control Test()
por: Brzoza, Zenon, et al.
Publicado: (2022)

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations
por: Kaplan, Allen P.
Publicado: (2017)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care
por: Savic, Sinisa, et al.
Publicado: (2015)

The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
por: Lobna, Matanis, et al.
Publicado: (2021)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
por: Casale, Thomas B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d6irdb79k8nuno7h96eke4n9t4